Medicinal Cannabis Matters: Friday Roundup - 16 January 2026

Calls for Change in Spain’s Medicinal Cannabis Framework

In Spain, pharmacists have raised concerns over proposed regulations that would restrict medicinal cannabis access to hospital-only settings. As reported by Business of Cannabis, professional bodies argue that limiting dispensing to hospitals could create unnecessary barriers for patients, particularly those managing long-term or complex conditions.

Pharmacists are calling for a model that allows for broader, community-based access under appropriate clinical supervision. While regulatory frameworks differ across countries, the discussion highlights a shared challenge across Europe: ensuring patient safety while avoiding restrictions that make treatment harder to access for those who need it most.

New Research Points to Sustained Relief in Treatment-Resistant Depression

New findings report that cannabis-based treatment may provide sustained symptom relief for patients living with treatment-resistant depression. The study followed patients over an extended period and found ongoing improvements in mood and overall wellbeing, particularly for those who had not responded to conventional therapies.

While further large-scale research is always needed, studies like this add to a growing body of evidence suggesting medicinal cannabis may have a role to play as part of a carefully managed treatment plan for certain mental health conditions, under specialist medical supervision.

Separating Fact From Headlines With Medicinal Cannabis Prescriptions

With medicinal cannabis continuing to attract media attention, this article gives a clear, balanced explainer on what medicinal cannabis prescriptions in the UK actually involve. The article addresses common misconceptions, clarifies who can be prescribed and explains how the process works within current regulations.

Importantly, it reinforces that medicinal cannabis is only prescribed when clinically appropriate, by specialist doctors, and as part of a regulated healthcare pathway. For patients considering their options, reliable information is key to making informed decisions.

From regulatory debates in Europe to expanding clinical evidence and clearer public information, it’s clear that medicinal cannabis care continues to evolve, with patient safety, access and evidence at the centre of the conversation.

If you’re considering whether medicinal cannabis could be right for you, you can check your eligibility online in just two minutes and explore your options with support from an experienced clinical team.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.